Late January - mid-February price target of R3 ($6.11).
R2 ($5.60) still being tested, another test and flip of support likely.
Before catalysts such as earnings, news or PR.
We've had a golden cross and high volume that's stayed constant. The MACD is still wide and shows no signs of narrowing long term. Likely, we're entering the consolidation phase before the next move up. If you want to enter, now is a good time. When news does arrive, we're definitely going to explode past R3, as $SPCE truly gets going (I personally see this as the most likely scenario). On the other hand, if another delay is to occur due to testing etc we will plummet substantially.
Next update before Earnings.
R2 ($5.60) still being tested, another test and flip of support likely.
Before catalysts such as earnings, news or PR.
We've had a golden cross and high volume that's stayed constant. The MACD is still wide and shows no signs of narrowing long term. Likely, we're entering the consolidation phase before the next move up. If you want to enter, now is a good time. When news does arrive, we're definitely going to explode past R3, as $SPCE truly gets going (I personally see this as the most likely scenario). On the other hand, if another delay is to occur due to testing etc we will plummet substantially.
Next update before Earnings.
